bpc 157 for ankylosing spondylitis Peptide Therapy 101: Can BPC-157 & Thymosin Beta-4 Accelerate Ortho-Recovery? BPC-157 is a peptide chain

Heres what the published literature shows

DSIP is an unapproved research chemical never approved by the FDA or EMA for any indication

After four to five half-lives, over 90% of the intact peptide is cleared

Sterile Technique Maintaining sterility prevents infection and ensures the peptide reaches tissue in active form

At baseline and at weeks 8 and 12, a clinician should assess fasting insulin and HOMA-IR (the homeostasis model assessment of insulin resistance, a calculated index derived from fasting glucose and insulin), HbA1c, high-sensitivity C-reactive protein as an inflammatory marker, and body composition by DEXA scan or bioelectrical impedance

Peptides, 3(6), 623626